Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADMA | AZN | AMGN | GILD | VRTX |
| Company | Adma Biologics | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 18.80 | 90.43 | 325.56 | 121.19 | 446.86 |
| High | 19.68 | 91.87 | 331.50 | 126.27 | 460.40 |
| Low | 18.80 | 90.36 | 324.73 | 121.00 | 445.51 |
| Latest | 19.58 | 91.36 | 327.38 | 124.29 | 456.20 |
| Change | +0.77 | +0.75 | +2.96 | +2.82 | +8.82 |
| % Change | +4.09% | +0.83% | +0.91% | +2.32% | +1.97% |
| Volume | 4,654,500 | 8,374,300 | 13,465,800 | 24,394,900 | 5,558,100 |
| 20-Day Average Volume | 3,004,940 | 5,998,660 | 3,398,425 | 7,806,410 | 1,598,600 |
| Previous Close | 18.81 | 90.61 | 324.42 | 121.47 | 447.38 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 19.34 | 91.05 | 330.49 | 123.03 | 443.33 |
| 20-Day Raw Stochastic | 78.88% | 43.93% | 44.11% | 60.71% | 81.78% |
| 20-Day Relative Strength | 60.72 | 57.71 | 53.42 | 54.27 | 59.60 |
| Weighted Alpha | +16.75 | +42.33 | +24.55 | +32.37 | +14.21 |
| Today's Opinion | 56% Buy | 100% Buy | 72% Buy | 88% Buy | 72% Buy |
| Previous Opinion | 40% Buy | 88% Buy | 72% Buy | 56% Buy | 72% Buy |
| Last Month's Opinion | 40% Sell | 100% Buy | 100% Buy | 100% Buy | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.01% since 12/12/25 | +1.70% since 12/12/25 | +3.03% since 12/12/25 | +3.23% since 12/12/25 | +0.92% since 12/12/25 |
| Low | 18.33 on 12/16/25 | 89.85 on 12/17/25 | 319.06 on 12/15/25 | 118.17 on 12/16/25 | 445.41 on 12/18/25 |
| High | 19.97 on 12/15/25 | 91.87 on 12/19/25 | 331.50 on 12/19/25 | 126.27 on 12/19/25 | 460.40 on 12/19/25 |
| 1-Month | |||||
| %Chg | +22.76% since 11/19/25 | +2.66% since 11/19/25 | -4.39% since 11/19/25 | -2.95% since 11/19/25 | +8.35% since 11/19/25 |
| Low | 16.23 on 11/20/25 | 88.41 on 11/20/25 | 312.39 on 12/11/25 | 118.17 on 12/16/25 | 420.00 on 11/20/25 |
| High | 20.46 on 12/12/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | +23.07% since 09/19/25 | +19.77% since 09/19/25 | +14.71% since 09/19/25 | +8.94% since 09/19/25 | +19.07% since 09/19/25 |
| Low | 13.76 on 11/07/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 20.46 on 12/12/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | +8.00% since 06/18/25 | +29.11% since 06/18/25 | +13.03% since 06/18/25 | +15.08% since 06/18/25 | +1.74% since 06/18/25 |
| Low | 13.76 on 11/07/25 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 20.46 on 12/12/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,660,001 | 283,346,272 | 176,287,920 | 154,204,128 | 115,746,608 |
| Shares Outstanding, K | 237,998 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 426,450,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | 197,670,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 134,220,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | 36,430,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 0.43 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.16 on 11/05/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 03/02/26 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 31.88 | 19.83 | 14.83 | 14.83 | 29.22 |